Parenteral glutamine protects hepatic function during bone marrow transplantation

Bone Marrow Transplantation

Volumn 22, Issue 3, 1998, Pages 281-284

  Brown, S A ^a   Goringe, A ^a   Fegan, C ^b   Davies, S V ^c   Giddings, J ^a   Whittaker, J A ^a   Burnett, A K ^a   Poynton, C H ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^c YEOVIL DISTRICT HOSPITAL   (United Kingdom)

Author keywords

Bone marrow transplantation; Glutamine; Glutathione; Hepatocellular dysfunction; Protein C

Indexed keywords

ALBUMIN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; GLUTAMINE; PLASMIN; PROTEIN C; THROMBIN;

ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER CELL; LIVER FUNCTION; LIVER VEIN OBSTRUCTION; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; THROMBIN TIME; VASCULAR ENDOTHELIUM;

EID: 0031857753     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701321     Document Type: Article

References (14)

1. Shulman HM, Hinterburger W. Hepatic veno-occlusive disease-liver toxicity syndrome after bone marrow transplantation. Bone Marrow Transplant 1992; 10: 197-214.
2. Bearman SI. The syndrome of hepatic veno-occlusive disease after bone marrow transplantation. Blood 1995; 85: 3005-3020.
3. McDonald GB, Hinds M, Fischer L et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation; a cohort study of 355 patients. Ann Intern Med 1993; 118: 255-267.
4. DeLeve LD, Kuklenkamp JF. Agents causing hepatic venoocclusive disease (HVOD) selectively kill sinusoidal endothelial cells (SECs): comon mechanism through GSH depletion. (Abstr.). Gastroenterology 1993; 104: 894a.
5. Teicher BA, Crawford JM, Holden SA et al. Glutathione monoethyl ester can selectively protect liver from high dose BCNU or cyclophosphamide. Cancer 1988; 62: 1275-1281.
6. Hong RW, Rounds JD, Helton WS et al. Glutamine preserves liver glutathione after lethal hepatic injury. Ann Surg 1992; 215: 114-119.
7. Rappaport AM, Knoblauch M, Zelin S et al. Experimental hepatic veno-occlusive disease. In vivo microcirculatory study. Adv Microcirc 1969; 2: 69-79.
8. Collins P, Roderick A, O'Brien D et al. Factor VIIa and other haemostatic variables following bone marrow transplantation. Thromb Haemost 1994; 72: 28-32.
9. Faioni E, Krachmalnicoff A, Bearman S et al. Naturally occurring anticoagulants and bone marrow transplantation: plasma protein C predicts the development of veno-occlusive disease of the liver. Blood 1993; 81: 3458-3462.
10. Gordon B, Haire W, Kessinger A et al. High frequency of antithrombin III and protein C deficiency following autologous bone marrow transplantation for lymphoma. Bone Marrow Transplant 1991; 8: 497-502.
11. Catani L, Gugliotta L, Mattioli M et al. Hypercoagulability in-patients undergoing autologous or allogeneic BMT for haematological malignancies. Bone Marrow Transplant 1993; 12: 253-259.
12. Scrobohaci M, Drouet L, Monem-Mansi A et al. Liver venoocclusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markers. Thromb Res 1991; 63: 509-519.
13. Kami M, Mon S, Tanikawa S et al. Risk factors for hepatic veno-occlusive disease after bone marrow transplantation: retrospective analysis of 137 cases at a single institution. Bone Marrow Transplant 1997; 20: 397-402.
14. Eltumi M, Trivedi P, Hobbs JR et al. Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III collagen. Lancet 1993; 342: 518-521.